Search results
James P. Allison (7 de agosto de 1948) es un inmunólogo estadounidense. Ocupa la cátedra de Inmunología y es el director ejecutivo de la plataforma de inmunoterapia en el M. D. Anderson Cancer Center. Sus descubrimientos se orientan hacia nuevos tratamientos para los tipos de cáncer más letales en humanos.
James Patrick Allison (born August 7, 1948) is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
James Allison is an American immunologist who discovered how to inhibit negative immune regulation and treat cancer. He shared the Nobel Prize with Tasuku Honjo for their groundbreaking work on cancer therapy by immune checkpoint blockade.
1 de oct. de 2018 · La Asamblea Nobel del Instituto Karolinska de Estocolmo les otorgó el Nobel de Medicina al estadounidense James P. Allison y el japonés Tasuku Honjo por haber descubierto una terapia contra...
Dr. James Allison is Regental Professor and Chair of the Department of Immunology, the Olga Keith Wiess Distinguished University Chair for Cancer Research, Director of the Parker Institute for Cancer Research, Executive Director of the... Read More.
2 de oct. de 2018 · En los años 90, el inmunólogo James P. Allison investigó una proteína conocida, CTLA-4, en su laboratorio de la Universidad de California en Berkeley. CTLA-4 es un receptor proteico que, funcionando como un punto de control inmunitario (immune checkpoint), disminuye las respuestas inmunitarias.
1 de oct. de 2018 · James P. Allison studied a known protein that functions as a brake on the immune system. He realized the potential of releasing the brake and thereby unleashing our immune cells to attack tumors. He then developed this concept into a brand new approach for treating patients.
